| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Caragol William J | Chief Financial Officer | MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ, GERMANY | /s/ William Caragol | 26 Jan 2026 | 0001380465 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MYNZ | Ordinary Shares | 0 | 01 Jan 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MYNZ | Employee Stock Option (Right to Buy) | 01 Jan 2026 | Ordinary Shares | 70,000 | $4.95 | Direct | F1 | ||||||
| holding | MYNZ | Employee Stock Option (Right to Buy) | 01 Jan 2026 | Ordinary Shares | 3,899 | $200.00 | Direct | F2 | ||||||
| holding | MYNZ | Employee Stock Option (Right to Buy) | 01 Jan 2026 | Ordinary Shares | 2,000 | $497.60 | Direct | F3 | ||||||
| holding | MYNZ | Employee Stock Option (Right to Buy) | 01 Jan 2026 | Ordinary Shares | 1,000 | $302.80 | Direct | F4 | ||||||
| holding | MYNZ | Employee Stock Option (Right to Buy) | 01 Jan 2026 | Ordinary Shares | 1,000 | $191.20 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | 50% of the option vested upon grant on 03/04/2025; the remaining balance vests 25% on 03/24/26 and 25% on 03/04/2027. |
| F2 | Fully vested. |
| F3 | Four-year vesting schedule: 25% vests on 04/29/2023, and the remainder vests 1/36 per month until 4/29/2026. |
| F4 | Four-year vesting schedule: 25% vests on 12/21/2023, and the remainder vests 1/36 per month until 12/21/2026. |
| F5 | Four-year vesting schedule: 25% vests on 06/30/2024, and the remainder vests 1/36 per month until 6/30/2076. |